| Name | Title | Contact Details |
|---|
DeRoyal manufactures quality healthcare products worldwide. DeRoyal is behind everything from the number one orthopedic hospital brand to online tools that power the medical industry. We keep innovating because it's part of our heritage.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Boston Medical Center Health Plan Inc is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PinnacleCare International is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Baltimore, MD. To find more information about PinnacleCare International, please visit www.pinnaclecare.com
With more than 26 billion medical claims and 7 million more added every day, we have the industry`s strongest and fastest growing data framework. Add the simple, at-a-glance visuals, and the personalized expertise from our data scientists and you have a full spectrum of tools that help validate strategies and optimize workflows that benefit providers, payers, and patients across your entire system.